Chuan Lai's departure as Chief Executive Officer of Vitaspring Biomedical Co. Ltd. was reported; the filing names no successor. As of November 6, 2026, Vitaspring Biomedical Co. Ltd. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 10, 2026, naming 2 appointments and 1 departure (Form 8-K, September 10, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Vitaspring Biomedical Co. Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Out · Person: Chuan Lai · Role: Chief Executive Officer · 8-K, 2026-09-10
- · In / out: In · Person: Zhou Chen · 8-K, 2026-09-10
- · In / out: In · Person: Hsiang Shih · Role: Chairman of the Board · 8-K, 2026-09-10
Vitaspring Biomedical Co. Ltd. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-10. It names 3 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Vitaspring Biomedical Co. Ltd. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-10 | Out | Chief Executive Officer | 8-K, 2026-09-10 | ||
| 2026-09-10 | In | 8-K, 2026-09-10 | |||
| 2026-09-10 | In | Chairman of the Board | 8-K, 2026-09-10 |
Selling to them or working with them? See who runs Vitaspring Biomedical Co. Ltd. now and the warning signs.
Free to see. No signup.
Watch Vitaspring Biomedical Co. Ltd.
Get an email when Vitaspring Biomedical Co. Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Vitaspring Biomedical Co. Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vitaspring Biomedical Co. Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vitaspring Biomedical Co. Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads Vitaspring Biomedical Co. Ltd., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chairman of the Board: Hsiang Shih, appointed (filed 2026-09-10).
- Chief Executive Officer: Chuan Lai, departure reported (filed 2026-09-10). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Vitaspring Biomedical Co. Ltd.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Vitaspring Biomedical Co. Ltd., with the record behind each one.
Find candidates like Chief Executive Officer at Vitaspring Biomedical Co. Ltd.Every change, in the filing's words
Departing: Chuan Lai, Chief Executive Officer
Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.
Appointed: Zhou Chen
The Board designated Mr. Chen as the Company's principal executive officer and as its principal financial officer and principal accounting officer.
Appointed: Hsiang Shih, Chairman of the Board
Pacific Time on September 7, 2026, Mr. Shih was appointed Chairman of the Board, to serve at the pleasure of the Board.
- (b) Resignation of Ssu-Chuan Lai Effective at 11:58 p.m.
- Dr. Lai's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- (c) Appointment of Jing-Zhou Chen as Chief Executive Officer, President, Chief Financial Officer and Secretary Effective at 11:57 p.m.
- Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company's Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.
- Mr. Chen, age 40, has served as the founder and Chief Executive Officer of Dream Born Co., Ltd., a Taiwan company that operates a mobile short-form video and consumer content application, since March 2025.
- From 2020 to 2025, Mr. Chen served as Chief Executive Officer and Managing Director of GBT Cloud Kitchen and of Hongxi Enterprise Management, affiliated Taiwan food service and franchising businesses.
- From 2018 to 2020, he was a co-founder and head of operations of POKE25, a blockchain-based gaming application.
- From 2017 to 2018, he served as Vice President of Operations of G-Store Smart Retail Technology, an unmanned retail equipment business.
Tools for this story
Each opens in a new tab, filled in for Vitaspring Biomedical Co. Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.